In the past week, NRSN stock has gone down by -1.61%, with a monthly gain of 78.83% and a quarterly surge of 128.78%. The volatility ratio for the week is 2.22%, and the volatility levels for the last 30 days are 5.73% for NeuroSense Therapeutics Ltd The simple moving average for the past 20 days is 29.49% for NRSN’s stock, with a 104.06% simple moving average for the past 200 days.
Is It Worth Investing in NeuroSense Therapeutics Ltd (NASDAQ: NRSN) Right Now?
The stock has a 36-month beta value of 1.63. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NRSN is 17.38M, and at present, short sellers hold a 1.76% of that float. On June 19, 2025, the average trading volume of NRSN was 247.20K shares.
NRSN) stock’s latest price update
The stock price of NeuroSense Therapeutics Ltd (NASDAQ: NRSN) has jumped by 2.08 compared to previous close of 2.40. Despite this, the company has seen a fall of -1.61% in its stock price over the last five trading days. benzinga.com reported 2025-05-12 that Last Wednesday, NeuroSense Therapeutics Ltd. NRSN said it scaled up its production of PrimeC to a commercial scale.
NRSN Trading at 74.12% from the 50-Day Moving Average
After a stumble in the market that brought NRSN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.77% of loss for the given period.
Stock Fundamentals for NRSN
The total capital return value is set at -3.83. Equity return is now at value -2880.11, with -263.45 for asset returns.
The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -4.11.
Currently, EBITDA for the company is -9.88 million with net debt to EBITDA at 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.21.
Conclusion
To sum up, NeuroSense Therapeutics Ltd (NRSN) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
